Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment
Baird Medical (NASDAQ: BDMD) recently sponsored an advanced Microwave Ablation (MWA) training session in New Orleans, focusing on thyroid nodule treatment. The program was led by Dr. Emad Kandil from Tulane University School of Medicine, with participation from Dr. Sean P. Nikravan and Dr. Erin H. Lin.
Participants observed seven live MWA procedures, gaining hands-on experience in precision targeting and workflow optimization. The training emphasized the technology's efficiency and potential for improved patient outcomes, including faster recovery times. Following the session, the physicians engaged in clinical discussions and received Certificates of Completion.
Chairwoman Haimei Wu emphasized the importance of hands-on training and expert collaboration in advancing MWA technology adoption for thyroid treatments.
Baird Medical (NASDAQ: BDMD) ha recentemente sponsorizzato una sessione avanzata di formazione sull'Ablazione a Microonde (MWA) a New Orleans, concentrandosi sul trattamento dei noduli tiroidei. Il programma è stato guidato dal Dr. Emad Kandil della Tulane University School of Medicine, con la partecipazione del Dr. Sean P. Nikravan e della Dr.ssa Erin H. Lin.
I partecipanti hanno osservato sette procedure MWA dal vivo, acquisendo esperienza pratica nel targeting di precisione e nell'ottimizzazione del flusso di lavoro. La formazione ha sottolineato l'efficienza della tecnologia e il suo potenziale per migliorare i risultati per i pazienti, inclusi tempi di recupero più rapidi. Al termine della sessione, i medici hanno partecipato a discussioni cliniche e hanno ricevuto Certificati di Completamento.
La Presidentessa Haimei Wu ha sottolineato l'importanza della formazione pratica e della collaborazione tra esperti per promuovere l'adozione della tecnologia MWA nei trattamenti tiroidei.
Baird Medical (NASDAQ: BDMD) patrocinó recientemente una sesión avanzada de capacitación en Ablación por Microondas (MWA) en Nueva Orleans, centrada en el tratamiento de nódulos tiroideos. El programa fue dirigido por el Dr. Emad Kandil de la Escuela de Medicina de la Universidad de Tulane, con la participación del Dr. Sean P. Nikravan y la Dra. Erin H. Lin.
Los participantes observaron siete procedimientos MWA en vivo, obteniendo experiencia práctica en la orientación precisa y la optimización de flujos de trabajo. La capacitación enfatizó la eficiencia de la tecnología y su potencial para mejorar los resultados de los pacientes, incluidos tiempos de recuperación más rápidos. Tras la sesión, los médicos participaron en discusiones clínicas y recibieron Certificados de Finalización.
La presidenta Haimei Wu enfatizó la importancia de la capacitación práctica y la colaboración experta para avanzar en la adopción de la tecnología MWA para tratamientos tiroideos.
Baird Medical (NASDAQ: BDMD)는 최근 루이지애나주 뉴올리언스에서 갑상선 결절 치료에 중점을 두고 고급 마이크로웨이브 절제(MWA) 교육 세션을 후원했습니다. 이 프로그램은 툴레인 대학교 의과대학의 Emad Kandil 박사가 이끌었으며, Sean P. Nikravan 박사와 Erin H. Lin 박사가 참여했습니다.
참가자들은 7개의 MWA 시술을 직접 관찰하며 정밀한 타겟팅 및 작업 흐름 최적화에 대한 실습 경험을 쌓았습니다. 교육은 이 기술의 효율성과 환자 결과 개선 잠재성, 더 빠른 회복 시간 등을 강조했습니다. 세션이 끝난 후, 의사들은 임상 토의에 참여하고 수료증을 받았습니다.
위원장 Haimei Wu는 갑상선 치료를 위한 MWA 기술 채택을 발전시키는 데 있어 실습 훈련과 전문가 협력의 중요성을 강조했습니다.
Baird Medical (NASDAQ: BDMD) a récemment parrainé une session de formation avancée en Ablation par Micro-ondes (MWA) à La Nouvelle-Orléans, axée sur le traitement des nodules thyroïdiens. Le programme était dirigé par le Dr Emad Kandil de l'École de Médecine de l'Université de Tulane, avec la participation du Dr Sean P. Nikravan et du Dr Erin H. Lin.
Les participants ont observé sept procédures MWA en direct, acquérant une expérience pratique en ciblage de précision et optimisation des flux de travail. La formation a souligné l'efficacité de la technologie et son potentiel pour améliorer les résultats pour les patients, y compris des temps de récupération plus rapides. À l'issue de la session, les médecins ont participé à des discussions cliniques et ont reçu des Certificats de Fin de Formation.
La Présidente Haimei Wu a souligné l'importance de la formation pratique et de la collaboration entre experts pour faire progresser l'adoption de la technologie MWA pour les traitements thyroïdiens.
Baird Medical (NASDAQ: BDMD) hat kürzlich eine fortgeschrittene Schulungssitzung zur Mikrowellenablation (MWA) in New Orleans gesponsert, die sich auf die Behandlung von Schilddrüsenknoten konzentrierte. Das Programm wurde von Dr. Emad Kandil von der Tulane University School of Medicine geleitet, mit Teilnahme von Dr. Sean P. Nikravan und Dr. Erin H. Lin.
Die Teilnehmer beobachteten sieben live MWA-Verfahren und erhielten praktische Erfahrungen in präziser Zielsetzung und Workflow-Optimierung. Das Training betonte die Effizienz der Technologie und ihr Potenzial für verbesserte Patientenergebnisse, einschließlich kürzerer Genesungszeiten. Nach der Sitzung beteiligten sich die Ärzte an klinischen Diskussionen und erhielten Abschlusszertifikate.
Die Vorsitzende Haimei Wu betonte die Bedeutung praktischer Schulungen und der Zusammenarbeit von Experten zur Förderung der Einführung der MWA-Technologie für Schilddrüsenbehandlungen.
- Successfully conducted training program demonstrating MWA technology to potential adopters
- Engagement of prominent medical professionals from major institutions
- Practical demonstration of technology through 7 live procedures
- None.
Insights
This training session represents an important step in Baird Medical's strategic market penetration efforts for their Microwave Ablation technology. The company's focus on physician education and hands-on training with high-profile medical institutions like Tulane University demonstrates a sophisticated commercialization strategy. Having influential physicians like Dr. Kandil lead these sessions creates valuable key opinion leader (KOL) relationships that are important for medical device adoption.
The participation of specialists from major institutions like UC Irvine indicates growing interest in MWA technology among leading medical centers. Training sessions that include live procedures are particularly effective for driving adoption, as they provide immediate practical experience and confidence in the technology. The emphasis on workflow efficiency and quick execution addresses key adoption barriers for new surgical technologies.
However, while this training program is well-executed, its immediate financial impact is The real value lies in the potential for accelerated market adoption and revenue growth in future quarters as trained physicians begin implementing the technology in their practices. For context, the thyroid ablation market is projected to reach
Led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, the session welcomed participation from Dr. Sean P. Nikravan, MD, FACE, an endocrinologist based in
Following the session, Dr. Nikravan and Dr. Lin participated in post-training discussions with Dr. Kandil, exchanging valuable clinical insights and strategies for adopting MWA in diverse clinical settings. Upon completing the program, both physicians were awarded Certificates of Completion, signifying their readiness to incorporate this advanced treatment modality into their practice.
"Advancing the development of MWA for thyroid nodules requires hands-on training and expert collaboration," said Haimei Wu, Chairwoman of Baird Medical. "By supporting specialized programs like this, we are empowering physicians with the practical expertise needed to refine patient care and drive broader adoption of minimally invasive thyroid treatments."
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.
These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.
Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-sponsored-microwave-ablation-training-advances-thyroid-treatment-302348718.html
SOURCE BDMD
FAQ
What was the purpose of Baird Medical's (BDMD) recent MWA training session in New Orleans?
How many live MWA procedures were performed during BDMD's training session?
Who led Baird Medical's (BDMD) MWA training program in New Orleans?
What are the key benefits of BDMD's Microwave Ablation technology for thyroid treatment?
